☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Expanded Label
Eli Lilly's Alimta (pemetrexed) + Keytruda (pembrolizumab) Receives FDA's Expanded Label Approval for 1L Metastatic Nonsquamous No...
January 31, 2019
Novartis' Kisqali (ribociclib) (as a Combination Therapy) Receives CHMP's Expanded Label Recommendation for HR+/HER2- Locally Adva...
November 19, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.